van Gils Lennart, Tchetche Didier, Lhermusier Thibault, Abawi Masieh, Dumonteil Nicolas, Rodriguez Olivares Ramón, Molina-Martin de Nicolas Javier, Stella Pieter R, Carrié Didier, De Jaegere Peter P, Van Mieghem Nicolas M
Erasmus Medical Center, Rotterdam, The Netherlands.
Clinique Pasteur, Toulouse, France.
J Am Heart Assoc. 2017 Mar 3;6(3):e005028. doi: 10.1161/JAHA.116.005028.
Right bundle branch block is an established predictor for new conduction disturbances and need for a permanent pacemaker (PPM) after transcatheter aortic valve replacement. The aim of the study was to evaluate the absolute rates of transcatheter aortic valve replacement related PPM implantations in patients with pre-existent right bundle branch block and categorize for different transcatheter heart valves.
We pooled data on 306 transcatheter aortic valve replacement patients from 4 high-volume centers in Europe and selected those with right bundle branch block at baseline without a previously implanted PPM. Logistic regression was used to evaluate whether PPM rate differed among transcatheter heart valves after adjustment for confounders. Mean age was 83±7 years and 63% were male. Median Society of Thoracic Surgeons score was 6.3 (interquartile range, 4.1-10.2). The following transcatheter valve designs were used: Medtronic CoreValve (n=130; Medtronic, Minneapolis, MN); Edwards Sapien XT (ES-XT; n=124) and Edwards Sapien 3 (ES-3; n=32; Edwards Lifesciences, Irvine, CA); and Boston Scientific Lotus (n=20; Boston Scientific Corporation, Marlborough, MA). Overall permanent pacemaker implantation rate post-transcatheter aortic valve replacement was 41%, and per valve design: 75% with Lotus, 46% with CoreValve, 32% with ES-XT, and 34% with ES-3. The indication for PPM implantation was total atrioventricular block in 98% of the cases. Lotus was associated with a higher PPM rate than all other valves. PPM rate did not differ between ES-XT and ES-3. Ventricular paced rhythm at 30-day and 1-year follow-up was present in 81% at 89%, respectively.
Right bundle branch block at baseline is associated with a high incidence of PPM implantation for all transcatheter heart valves. PPM rate was highest for Lotus and lowest for ES-XT and ES-3. Pacemaker dependency remained high during follow-up.
右束支传导阻滞是经导管主动脉瓣置换术后新发传导障碍及需要植入永久性起搏器(PPM)的既定预测指标。本研究的目的是评估存在右束支传导阻滞的患者经导管主动脉瓣置换相关PPM植入的绝对发生率,并对不同的经导管心脏瓣膜进行分类。
我们汇总了来自欧洲4个高容量中心的306例经导管主动脉瓣置换患者的数据,并选择了基线时存在右束支传导阻滞且此前未植入PPM的患者。采用逻辑回归分析评估在调整混杂因素后,不同经导管心脏瓣膜的PPM发生率是否存在差异。平均年龄为83±7岁,63%为男性。胸外科医师协会评分中位数为6.3(四分位间距,4.1 - 10.2)。使用了以下经导管瓣膜设计:美敦力CoreValve(n = 130;美敦力公司,明尼阿波利斯,明尼苏达州);爱德华兹Sapien XT(ES - XT;n = 124)和爱德华兹Sapien 3(ES - 3;n = 32;爱德华兹生命科学公司,尔湾,加利福尼亚州);以及波士顿科学公司的Lotus(n = 20;波士顿科学公司,马尔伯勒,马萨诸塞州)。经导管主动脉瓣置换术后总体永久性起搏器植入率为41%,按瓣膜设计分别为:Lotus为75%,CoreValve为46%,ES - XT为32%,ES - 3为34%。98%的病例中PPM植入的指征为完全性房室传导阻滞。Lotus与所有其他瓣膜相比,PPM发生率更高。ES - XT和ES - 3之间的PPM发生率无差异。在30天和1年随访时,心室起搏心律分别为81%和89%。
基线时的右束支传导阻滞与所有经导管心脏瓣膜的PPM植入高发生率相关。Lotus的PPM发生率最高,ES - XT和ES - 3最低。随访期间起搏器依赖率仍然很高。